TG Therapeutics Inc (NASDAQ:TGTX)

Delayed Data
As of May 18
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 28.50, with a high estimate of 38.00 and a low estimate of 22.00. The median estimate represents a +102.85% increase from the last price of 14.05.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 28.66%
Growthannually -6.98%


Growthquarterly 0.66%
Growthannually 0.08%
Key to the earnings and sales forecast charts.